Annovis Bio Inc Corporate Update Webinar Transcript
Hello everyone, welcome. Thank you for joining today. My name is [Brooke] and I'm delighted to welcome you to the Annovis webinar. Today we will provide the company's update and answer questions from the audience.
Before we begin, I would like to remind everyone that today's call may include forward-looking date dates. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to different materially those projected.
For more information on the risks and uncertainties related to Annovis Bio business, please refer to the forward statements and the complement of the latest SEC filings.
To guide us to today's presentation, I am pleased to introduce our speaker, Dr. Ria Machimini, the founder, friend, and CEO of ANOVA BiBio. Today's presentation will address current progress of Alzheimer's and Parkinson clinical programs, including the inhabitable phase-albound trial, the upcoming open-label-label engine, short EBITDA, and the ongoing appointment late extension, short BPD.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
